Microbix Biosystems Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 10, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Cap	39	37	46	42	71	80
Market Cap Growth	-17.98%	-19.43%	7.96%	-40.15%	-10.97%	181.52%
Enterprise Value	37.93	31.35	38.99	37.2	62.95	74.71
Last Close Price	0.28	0.27	0.34	0.31	0.51	0.63
PE Ratio	-	-	12.88	-	39.23	24.23
PS Ratio	2.65	1.99	1.80	2.57	3.72	4.28
PB Ratio	1.56	1.33	1.62	1.72	2.84	4.29
P/TBV Ratio	1.57	1.33	1.64	1.74	2.90	4.81
P/FCF Ratio	-	-	16.89	-	49.24	92.16
P/OCF Ratio	-	-	10.53	-	20.46	37.79
EV/Sales Ratio	2.56	1.69	1.54	2.25	3.30	4.02
EV/EBITDA Ratio	-	425.27	7.07	-	17.26	13.20
EV/EBIT Ratio	-	-	9.99	-	24.12	15.45
EV/FCF Ratio	-	-	14.38	-	43.73	86.48
Debt / Equity Ratio	0.23	0.24	0.22	0.26	0.22	0.27
Debt / EBITDA Ratio	-	91.91	1.16	-	1.60	1.37
Debt / FCF Ratio	-	-	2.36	-	4.05	8.95
Net Debt / Equity Ratio	-0.05	-0.19	-0.23	-0.20	-0.31	-0.12
Net Debt / EBITDA Ratio	0.24	-72.42	-1.19	1.07	-2.10	-0.40
Net Debt / FCF Ratio	0.24	6.08	-2.42	2.35	-5.32	-2.61
Asset Turnover	0.41	0.49	0.69	0.48	0.62	0.84
Inventory Turnover	0.88	1.12	1.64	1.64	1.64	1.74
Quick Ratio	2.77	4.94	5.05	3.63	6.25	2.73
Current Ratio	5.35	8.48	7.15	5.13	8.45	3.68
Return on Equity (ROE)	-22.11%	-8.01%	13.30%	-0.16%	8.22%	25.69%
Return on Assets (ROA)	-20.33%	-4.29%	10.20%	-16.90%	8.23%	21.77%
Return on Invested Capital (ROIC)	-28.65%	-7.08%	16.94%	-29.23%	14.62%	31.14%
Return on Capital Employed (ROCE)	-22.77%	-4.92%	11.83%	-18.82%	9.64%	27.53%
Earnings Yield	-	-	7.76%	0.00%	2.55%	4.13%
FCF Yield	-	-	5.92%	-	2.03%	1.09%
Buyback Yield / Dilution	0.80%	-0.48%	-0.42%	2.67%	-0.00%	-26.40%
Total Shareholder Return	0.80%	-0.48%	-0.42%	2.67%	-0.00%	-26.40%